Furthermore, ICV-STZ has now been found to induce cognitive impairment and neuron damage [48], oxidative stress [49] and glucose/energy metabolism damage in the brain [50], insulin resistance in the brain [51,52], and finally lead to Tau hyperphosphorylation and Aβ deposition [53,54]. The gene discussed is MAPT; the disease is Cognitive impairment.